Клинико-генетические исследования шизофрении в контексте дименсиональной модели

А. Н. Нестерович, В. Г. Объедков Республиканский научно-практический центр психического здоровья, УО «Белорусский государственный медицинский университет»

2014 №4 | Лекции

Аннотация

Список литературы

Скачать полнотекстовую статью

В статье приводится обзор литературы, посвященной генетическим исследованиям отдельных фенотипических паттернов шизофрении (т. н. «дименсий») – продуктивных симптомов, негативных симптомов и дезорганизации. Анализ наследуемости фенотипа в семьях, а также результаты молекулярно-генетических исследований указывают на то, что негативные симптомы шизофрении, а также дезорганизация наследуемы в большей степени, чем бред и галлюцинации, и могут быть детерминированы т. н. «генами-посредниками». Обнаружение новых «генов-посредников» шизофрении в контексте дименсиональной модели позволит лучше понять природу заболевания и выявить новые, потенциально модифицируемые механизмы патогенеза данного заболевания

Ключевые слова:

шизофрения, дименсиональная модель, дименсии, симптомы, клинические, генетика, генетические, гены

Clinical-genetic investigations of schizophrenia in the context of dimensional model

The article provides the overview of the literature concerning genetic investigations of single phenotypic traits of schizophrenia («dimensions») – positive symptoms, negative symptoms and disorganization. The analysis of phenotypic traits heritability in family and the results of the molecular genetic studies show that the negative symptoms of schizophrenia and disorganization are heritable to a greater extent compared to delusions and hallucinations and can be determined by the so-called «modifier-genes». Search for the new «modifier-genes» in the context of schizophrenia dimensional model may contribute to better understanding of disease nature and to discover new potentially modifiable mechanisms of its pathogenesis.

Keywords

schizophrenia, dimensional model, dimensions, symptoms, clinical, genetics, genes

1. Allen-Brady, K. Genome-wide linkage in Utah autism pedigrees / K. Allen-Brady [et al.] // Molecular Psychi atry. – 2010. – Vol. 15. – P. 1006–15.
2. Andreasen, N. Remission in Schi zophr enia: Proposed Cri teri a and Rationale for Consensus / N. Andreasen [et al.] // The Ameri can Journal of Psychi atry. – 2005. – Vol. 162. – P. 441–9.
3. Arinami, T. Association of dopamine D2 receptor molecular vari ant with schi zophr enia / T. Ari mani [et al.] // Lancet. – 1994. – Vol. 343. – P. 703–4.
4. Bilder, R. Symptomatic and neuropsychological components of defect states / R. Bilder [et al.] // Schi zophr . Bull. – 1985. – Vol. 11. – P. 409–19.
5. Cardno, A. Twin study of symptom dimensions in psychoses / A. Cardno [et al.] // Br. J. Psychi atry. – 2001. – Vol. 179. – P. 39–45.
6. Cardno, A. CAG repeat length in the hKCa3 gene and symptom dimensions in schi zophr enia / A. Cardno [et al.] // Biol. Psychi atry. – 1999. – Vol. 45. – P. 1592–6.
7. Chen, P. Fine mapping on chr omosome 10q22-q23 implicates Neuregulin3in schi zophr enia / P. Chen [et al.] // Ameri can Journal of Human Genetics. – 2009. – Vol. 84. – P. 21–34.
8. Delisi, L. Clinical features of illness in siblings with schi zophr enia or schi zoaffective disorder / L. Delisi [et al.] // Arch. Gen. Psychi atry. – 1987. – Vol. 44. – P. 891–6.
9. Derosse, P. Dysbindin genotype and negative symptoms in schi zophr enia / P. Derosse [et al.] // Am. J. Psychi atry. – 2006. – Vol. 163. – P. 532–4.
10. Derosse, P. Disrupted in schi zophr enia 1 genotype and positive symptoms in schi zophr enia / P. Derosse [et al.] // Biol. Psychi atry. – 2006. – Vol. 61 (10). – P. 1208–10.
11. Fanous, A. Relationshi p between a hi gh-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schi zophr enia / A. Fanous [eta l.] // Am. J. Psychi atry. – 2005. – Vol. 162. – P. 1824–32.
12. Fanous, A., Kendler, K., Genetic heterogeneity, modifier genes, and Quantitative phenotypesin psychi atri c illness: searchi ng for a framework / A. Fanous, K. Kendler // Molecular Psychi atry. – 2005. – Vol. 10. – P. 6–13.
13. Fanous, A. Genome-wide association study of clinical dimensions of schi zophr enia: polygenic effect on disorganized symptoms / A. Fanous [et al.] // American Journal of Psychi atry. – 2012. – Vol. 169. – P. 1309–17.
14. Fanous, A. Clinical features of psychotic disorders and polymorphi sms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study / A. Fanous [et al.] // Ameri can Journal of Medical Genetics PartB: Neuropsychi atri c Genetics. – 2004. – Vol. 125B. – P. 69–78.
15. Hong, K. Genome-widely significant evidence of linkage of schi zophr enia to chr omosomes 2p24.3and 6q27inan SNP-Based analysis of Korean families / K. Hong [et al.] // Ameri can Journal of Medical Genetics Part B: Neuropsychi atri c Genetics. – 2009. – Vol. 150B. – P. 647–52.
16. Hwu, H. Concordance of positive and negative symptoms in coaffected sib-pair s with schi zophr enia / H. Hwu [et al.] // Am. J. Med. Genet. – 1997. – Vol. 74. – P. 1–6.
17. Jang, Y. Linkage ofschi zophr eniawithchr omosome 1q32 in Korean multiplex families / Y. Jang [et al.] // Ameri can Journal of Medical Genetics Part B: Neuropsychi atri c Genetics. – 2007. – Vol. 144B. – P. 279–84.
18. Liddle, P. The symptoms of chr onic schi zophr enia. A re-examination of the positive–negative dichotomy / P. Liddle // Br. J. Psychi atry. – 1987. – Vol. 151 (2). – P. 145–51.
19. Liu, Y. Replication of an association of a common vari ant in the Reelin gene (RELN) with schi zophr eniain Ashkenazi Jewish women / Y. Liu [et al.] // Psychi atri c Genetics. – 2010. – Vol. 20. – P. 184–6.
20. McGrath, J. Familiality of novel factori al dimensions of schi zophr enia / J. McGrath [et al.] // Archi ves of General Psychi atry. – 2009 – Vol. 66. – P. 591–600.
21. Ni, X. Connexin 50 gene on human chr omosome 1q21 is associated with schi zophr enia in matched case control and family-based studies / X. Ni [et al.] // J. Med. Genet. – 2007. – Vol. 44. – P. 532–6.
22. Nicoll, R. The coupling of neurotransmitter receptors to ion channels in the brain / R. Nicoll // Science. – 1988. – Vol. 241. – P. 545–51.
23. Neale, M. The power of the classical twin study to resolve vari ation in thr eshold traits / M. Neale [et al.] // Behavior. Genetics. – 1994. – Vol. 24. – P. 239–58.
24. O′Brien, E. Association of specific language impair ment (SLI) to the region of 7q31 / E. O’Bri en [et al.] // Ameri can Journal of Human Genetics. – 2003. – Vol. 72. – P. 1536–43.
25. Rietkerk, T. The genetics of symptom dimensions of schi zophr enia: Review and meta- analysis / T. Ri etkerk [et al.] // Schi zophr enia Research. – 2008. – Vol. 102. – P. 197–205.
26. Rosa, A. 1q21–q22 locus is associated with susceptibility to the reality-distortion syndrome of schi - zophr enia spectrum disorders / A. Rosa [et al.] // Am. J. Med. Genet. – 2002. – Vol. 114. – P. 516–18.
27. Serretti, A. DRD4exon3vari ants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects / A. Seretti [et al.] // Ameri can Journal of Medical Genetics. – 2001. – Vol. 105. – P. 283–90.
28. Serretti, A. Dopamine receptor D2 Ser/Cys 311 vari ant is associated with delusion and disorganization symptomatology in major psychoses / A. Seretti [et al.] // Mol. Psychi atry. – 2000. – Vol. 5. – P. 270–4.
29. Seunghyong, Ryu. Genome-wide linkage scan of quantitative traits representing Symptom dimensions in multiplex schi zophr enia families / Seunghyong Ryu [et al.] // Psychi atry Research. – 2013. – Vol. 210. – P. 756–60.
30. Shinkai, T. Polymorphi sms of tryptophan hydroxylase gene and the symptomatology of schi zophr enia: an association study / T. Shi nkai [et al.] // Psychi atr. Genet. – 2000. – Vol. 10. – P. 165–71.
31. Sun, J. Investigating association off our gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schi zophr enia / J. Sun [et al.] // Psychi atry Research. – 2012. – Vol. 198. – P. 202–6.
32. Torgersen, S. Schi zotypal personality disorder inside and outside the schi zophr enic spectrum / S. Torgersen [et al.] // Schi zophr . Res. – 2002. – Vol. 54. – P. 33–8.
33. Vazza, G. Genome-wide scan supports the existence of a susceptibility locus for schi zophr enia and bipolar disorder on chr omosome 15q26 / G. Vazza [et al.] // Molecular Psychi atry. – 2007. – Vol. 12. – P. 87–93.
34. Wilcox, M. Genome scan of thr ee quantitative traits in schi zophr enia pedigrees / M. Wilcox [et al.] // Biol. Psychi atry. – 2002. – Vol. 52. – P. 847–54.
35. Wickham, H. Familiality of symptom dimensions in schi zophr enia / H. Wickham [et al.] // Schi zophr . Res. – 2001. – Vol. 47. – P. 223–32.
36. Zhang, X. The CCK-A receptor gene possibly associated with positive symptoms of schi zophr enia / X. Zhang [et al.] // Molecular Psychi atry. – 2000. – Vol. 5. – P. 239–40.